Mikael Dolsten - Feb 22, 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role
President R&D
Signature
Susan E. Grant, by power of atty., for Mikael Dolsten
Stock symbol
PFE
Transactions as of
Feb 22, 2023
Transactions value $
-$1,381,249
Form type
4
Date filed
2/24/2023, 07:18 PM
Previous filing
Nov 9, 2022
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Tax liability -$1.38M -32.6K -7.69% $42.38 391K Feb 22, 2023 Direct F1
holding PFE Common Stock 1.88K Feb 22, 2023 By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Award $0 +138K $0.00 138K Feb 23, 2023 Common Stock 138K $42.30 Direct F2
transaction PFE Stock Appreciation Rights Award $0 +120K $0.00 120K Feb 23, 2023 Common Stock 120K $42.30 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).
F2 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F3 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.